Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 1, 2011, Pages 67-75

  Frazzoni, M ^a   Conigliaro, R ^a   Manta, R ^a   Melotti, G ^a  

^a Nuovo Ospedale S Agostino   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DRUG DOSE REGIMEN; DRUG MEGADOSE; ESOPHAGOSCOPY; ESOPHYX; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MALE; OPEN STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; STOMACH FUNDOPLICATION; SYMPTOM; TREATMENT INDICATION;

ESOPHAGEAL PH MONITORING; FOLLOW-UP STUDIES; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; LAPAROSCOPY; MANOMETRY; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; REGURGITATION, GASTRIC; TREATMENT OUTCOME;

EID: 79958158150     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04677.x     Document Type: Article

References (40)

1. DeVault KR, Castell DO,. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200. (Pubitemid 41623288)
2. Fass R, Sifrim D,. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309.
3. Kahrilas PJ, Shaheen NJ, Vaezi MF,. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135: 1392-413.
4. Broeders JA, Rijnhart-de Jong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG,. Ten-year outcome of laparoscopic and conventional Nissen fundoplication. Ann Surg 2009; 250: 698-706.
5. Cadiàre GB, Rajan A, Germay O, Himpens J,. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc 2006; 22: 333-42.
6. Cadiere GB, Buset M, Muls V, et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 2008; 32: 1676-88.
7. Bredenoord AG, Tutuian R, Smout AJPM, Castell DO,. Technology review: esophageal impedance monitoring. Am J Gastroenterol 2006; 101: 1-8.
8. Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402. (Pubitemid 44476780)
9. Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 1956-63. (Pubitemid 44337616)
10. Pandolfino JE, Vela MF,. Esophageal reflux monitoring. Gastrointest Endosc 2009; 69: 917-30.
11. Frazzoni M, Grisendi A, Lanzani A, Melotti G, De Micheli E,. Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison. Dig Liver Dis 2002; 34: 99-104. (Pubitemid 34202066)
12. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-80. (Pubitemid 29333764)
13. Hill LD, Kozarek RA, Kraemer SJ, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc 1996; 44: 541-7. (Pubitemid 26386898)
14. Sifrim D, Castell D, Dent J, Kahrilas PJ,. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-31. (Pubitemid 38824163)
15. Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther 2009; 30: 508-15.
16. Zerbib F, Duriez A, Roman S, Capdepont M, Mion F,. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008; 57: 156-60. (Pubitemid 351158039)
17. Tutuian R, Vela MF, Hill EG, Mainie I, Agrawal A, Castell DO,. Characteristic of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol 2008; 103: 1090-6. (Pubitemid 351677992)
18. Repici A, Fumagalli U, Malesci A, Barbera R, Gambaro C, Rosati R,. Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg 2010; 14: 1-6.
19. Furnée EJB, Broeders JAJL, Draaisma WA, et al. Laparoscopic Nissen fundoplication after failed EsophyX fundoplication. Br J Surg 2010; 97: 1051-5.
20. Bredenoord AJ, Draaisma WA, Weusten BLAM, Gooszen HG, Smout AJPM,. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 2008; 57: 161-6. (Pubitemid 351158040)
21. Scheffer RCH, Samsom M, Hebbard GS, Gooszen HG,. Effects of partial (Belsey Mark IV) and complete (Nissen) fundoplication on proximal gastric function and esophagogastric junction dynamics. Am J Gastroenterol 2006; 101: 479-87. (Pubitemid 43340922)
22. Roman S, Poncet G, Serray I, Zerbib F, Boulez J, Mion F,. Characterization of reflux events after fundoplication using combined impedance-pH recording. Br J Surg 2007; 94: 48-52. (Pubitemid 46142731)
23. Frazzoni M, Conigliaro R, Melotti G,. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci 2011; 56: 1099-106.
24. Frazzoni M, Conigliaro R, Melotti G,. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther 2011; 33: 601-6.
25. Roberts NB,. Review article: human pepsins-their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther 2006; 24 (Suppl. 2): 2-9. (Pubitemid 44267777)
26. Pearson JP, Parikh S,. Review article: nature and properties of gastro-oesophageal and extra-oesophageal refluxate. Aliment Pharmacol Ther 2011; 33 (Suppl. 1): 2-7.
27. Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO,. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 2009; 22: 467-70.
28. Aanen MC, Bredenoord AJ, Numans ME, Samsom M, Smout AJ,. Reproducibility of symptom association analysis in ambulatory reflux monitoring. Am J Gastroenterol 2008; 103: 2200-8.
29. Hemmink GJM, Bredenoord AJ, Weusten BLAM, Monkelbaan JF, Timmer M, Smout AJPM,. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: "on" or "off" proton pump inhibitor? Am J Gastroenterol 2008; 103: 2446-53.
30. Pritchett JM, Aslam M, Slaughter JC, Ness RM, Garrett CG, Vaezi MF,. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009; 7: 743-8.
31. Spechler JS,. Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol 2009; 7: 1264-5.
32. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH-monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99: 1037-43. (Pubitemid 38917805)
33. Zerbib F, Bruley Des Varannes S, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22: 1011-21. (Pubitemid 41634884)
34. Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 2006; 38: 226-32. (Pubitemid 44356183)
35. Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and non-erosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol 2010; 105: 1053-61.
36. Hila A, Agrawal A, Castell DO,. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007; 5: 172-7. (Pubitemid 46216940)
37. Benson K, Hartz A,. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342: 1878-86. (Pubitemid 30419053)
38. Concato J, Shah N, Horwitz RI,. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-92. (Pubitemid 30419054)
39. Dellon ES, Shaheen NJ,. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease. Gastroenterology 2010; 139: 7-13.
40. Broeders JAJL, Bredenoord AJ, Hazebroek EJ, Broeders IAMJ, Gooszen HG, Smout AJPM,. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut 2011; 60: 435-41.